Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The BCG story: lessons from the past and implications for the future.

Fine PE.

Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S353-9. Review.

PMID:
2652252
2.

Recent progress in the development and testing of vaccines against human tuberculosis.

McMurray DN.

Int J Parasitol. 2003 May;33(5-6):547-54. Review.

PMID:
12782054
3.

Does bacille Calmette-Guérin scar size have implications for protection against tuberculosis or leprosy?

Sterne JA, Fine PE, Pönnighaus JM, Sibanda F, Munthali M, Glynn JR.

Tuber Lung Dis. 1996 Apr;77(2):117-23.

PMID:
8762845
4.

New strategies for leprosy and tuberculosis and for development of bacillus Calmette-Guérin into a multivaccine vehicle.

Bloom BR, Jacobs WR Jr.

Ann N Y Acad Sci. 1989;569:155-73. Review. No abstract available.

PMID:
2516995
5.

[BCG vaccines for the prevention of tuberculosis in the world].

Hashimoto T.

Kekkaku. 1997 Nov;72(11):629-37. Japanese.

PMID:
9423301
6.

Recent developments in tuberculosis vaccines.

Haile M, Källenius G.

Curr Opin Infect Dis. 2005 Jun;18(3):211-5. Review.

PMID:
15864097
7.

The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.

Zodpey SP.

Indian J Public Health. 2004 Apr-Jun;48(2):70-7.

PMID:
15709589
8.

Deciphering the story of Bacillus Calmette Guerin (BCG) vaccine in prevention of leprosy.

Zodpey SP.

Indian J Public Health. 2006 Apr-Jun;50(2):67-9. Review. No abstract available.

9.

BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.

Liu J, Tran V, Leung AS, Alexander DC, Zhu B.

Hum Vaccin. 2009 Feb;5(2):70-8. Epub 2009 Feb 20. Review.

PMID:
19164935
10.

Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.

Pönnighaus JM, Fine PE, Sterne JA, Wilson RJ, Msosa E, Gruer PJ, Jenkins PA, Lucas SB, Liomba NG, Bliss L.

Lancet. 1992 Mar 14;339(8794):636-9.

PMID:
1347338
11.

BCG vaccination against tuberculosis: past disappointments and future hopes.

Roche PW, Triccas JA, Winter N.

Trends Microbiol. 1995 Oct;3(10):397-401. Review.

PMID:
8564359
12.

New vaccines for the prevention of tuberculosis.

von Reyn CF, Vuola JM.

Clin Infect Dis. 2002 Aug 15;35(4):465-74. Epub 2002 Jul 24.

PMID:
12145732
13.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
14.

Comparative genomics of BCG vaccines.

Behr MA.

Tuberculosis (Edinb). 2001;81(1-2):165-8. Review.

PMID:
11463238
15.

Applying experiences from trials of bacille Calmette-Guérin vaccine.

Wilson ME.

Clin Infect Dis. 2000 Jun;30 Suppl 3:S262-5. Review.

PMID:
10875796
16.

The success and failure of BCG - implications for a novel tuberculosis vaccine.

Andersen P, Doherty TM.

Nat Rev Microbiol. 2005 Aug;3(8):656-62. Review.

PMID:
16012514
17.

Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.

Franco-Paredes C, Rouphael N, del Rio C, Santos-Preciado JI.

Int J Infect Dis. 2006 Mar;10(2):93-102. Epub 2005 Dec 22. Review.

18.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
19.

Influence of BCG vaccine strain on the immune response and protection against tuberculosis.

Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N.

FEMS Microbiol Rev. 2008 Aug;32(5):821-41. doi: 10.1111/j.1574-6976.2008.00118.x. Epub 2008 Jul 9. Review.

20.

DNA encoding a single mycobacterial antigen protects against leprosy infection.

Martin E, Roche PW, Triccas JA, Britton WJ.

Vaccine. 2001 Jan 8;19(11-12):1391-6.

PMID:
11163661

Supplemental Content

Support Center